Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,582,816
-$215,332 QoQ
Shares Held
44,825
-2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#737
of 2,514 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $103,613,510 across 8 Drug Manufacturers - General names. BMY ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,592 | $42,690,116 | |
| 2 | ABBV |
AbbVie Inc.
|
157,662 | $39,674,065 | |
| 3 | JNJ |
Johnson & Johnson
|
34,927 | $8,870,410 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,543 | $6,237,775 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
44,825 | $2,582,816 | |
| 6 | PFE |
Pfizer Inc
|
75,072 | $1,807,733 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,640 | $1,217,917 | |
| 8 | AMGN |
Amgen Inc
|
1,471 | $532,678 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,582,816 | 44,825 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,798,148 | 46,136 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,604,115 | 48,278 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,086,601 | 90,612 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,719,178 | 145,154 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,781,759 | 160,383 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,496,819 | 167,907 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,703,495 | 168,216 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,198,809 | 149,261 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $17,954,576 | 331,082 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,062,903 | 313,056 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $12,759,223 | 219,835 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $23,457,691 | 366,813 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $25,103,804 | 362,196 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,060,760 | 348,308 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $23,082,709 | 324,697 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,719,635 | 100,255 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $21,461,514 | 321,184 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $20,396,797 | 323,092 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $18,435,005 | 297,195 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $18,020,560 | 298,898 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $22,028,773 | 374,639 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $24,920,294 | 447,081 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||